FARALLON CAPITAL MANAGEMENT, L.L.C.
Institutional investor · Portfolio as of Q2 2024
Top Holdings167 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
STATE STREET SPDR S&P 500 ETF TRUST CL USD INC | 8.9M | $4.8B | 20.8% | — | — | — | Decreased — |
HESS CORP | 6.8M | $1B | 4.3% | — | — | 3 qtrssince 2023-Q4 | Increased 62 |
ISHARES RUSSELL 2000 ETF ETF | 4.3M | $862.3M | 3.7% | — | — | — | New — |
UNITEDHEALTH GROUP INC | 1.6M | $824.1M | 3.5% | $458.87 | +7.52% | 6 qtrssince 2023-Q1 | Decreased 0 |
SALESFORCE.COM INC | 2.9M | $757.6M | 3.3% | $201.91 | +25.97% | 19 qtrssince 2019-Q4 | Increased 81 |
IQVIA HOLDINGS INC | 2.9M | $618M | 2.7% | $165.53 | +27.74% | 23 qtrssince 2018-Q4 | Increased 56 |
EXELIXIS INC | 27.1M | $609M | 2.6% | $19.15 | +17.33% | 23 qtrssince 2018-Q4 | Increased 55 |
ARAMARK | 16.9M | $575.9M | 2.5% | $25.80 | +29.00% | 15 qtrssince 2020-Q4 | Decreased 0 |
AON PLC | 1.9M | $550.5M | 2.4% | $303.01 | -4.32% | 2 qtrssince 2024-Q1 | Increased 87 |
MICROSOFT CORP | 1.2M | $537.6M | 2.3% | $214.60 | +105.96% | 23 qtrssince 2018-Q4 | Decreased 0 |
NEW YORK TIMES CO-A | 9.9M | $508M | 2.2% | $41.34 | +21.40% | 17 qtrssince 2020-Q2 | Decreased 0 |
NATERA INC | 4.5M | $483M | 2.1% | $65.58 | +65.13% | 13 qtrssince 2021-Q2 | Increased 61 |
ISHARES BIOTECHNOLOGY ETF | 3.5M | $480.4M | 2.1% | — | — | — | Unchanged — |
NASDAQ OMX GROUP/THE | 7.5M | $452.4M | 1.9% | $57.63 | +2.63% | 4 qtrssince 2023-Q3 | Decreased 0 |
TRANSUNION | 6M | $447.6M | 1.9% | $86.03 | -14.44% | 23 qtrssince 2018-Q4 | Decreased 0 |
CATALENT INC | 7.6M | $427.3M | 1.8% | — | — | 3 qtrssince 2023-Q4 | Increased 79 |
INTUIT INC | 629,097 | $413.4M | 1.8% | $422.31 | +53.85% | 7 qtrssince 2022-Q4 | Increased 57 |
THERMO FISHER SCIENTIFIC INC | 739,156 | $408.8M | 1.8% | $432.36 | +27.28% | 19 qtrssince 2019-Q4 | Decreased 0 |
REVOLUTION MEDICINES INC | 9.8M | $378.7M | 1.6% | $31.41 | +23.56% | 14 qtrssince 2021-Q1 | Increased 62 |
AVI BIOPHARMA INC | 2.3M | $362.6M | 1.6% | $115.75 | +36.50% | 12 qtrssince 2021-Q3 | Decreased 0 |
FARALLON CAPITAL MANAGEMENT, L.L.C. manages $23.3B across 167 positions as of Q2 2024. Top holdings: SPY (20.8%), HES (4.3%), IWM (3.7%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 1.5/5.0.
Active quarter - 20 new positions, 30 exits, 32 increased. Top move: AON (INCREASED, conviction 87). Portfolio: $23.3B across 167 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer